n/a
Article Publish Status: FREE
Abstract Title:

The Efficacy ofSeed on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial.

Abstract Source:

Evid Based Complement Alternat Med. 2021 ;2021:6693887. Epub 2021 Mar 27. PMID: 33854559

Abstract Author(s):

Seyedeh Ferdows Jazayeri, Roshanak Ghods, Fataneh Hashem Dabaghian, Asie Shojaii, Seyed Ali Al-Hadi Moravej, Ebrahim Khadem, Seyed Saeed Seyedian

Article Affiliation:

Seyedeh Ferdows Jazayeri

Abstract:

Objective: This study aims to evaluate the effects of() seed on liver enzymes and ultrasound patterns in nonalcoholic fatty liver disease (NAFLD).

Design: In this randomized double-blind placebo-controlled clinical trial, 74 patients with NAFLD were administered either 2 gor placebo twice daily for 12 weeks. All patients were advised to follow the recommendations for daily exercise and diet modification. Levels of liver enzymes as well as other laboratory indexes were measured at the beginning of the study and after 12 weeks. Indeed, the alteration in ultrasound grade was evaluated in NAFLD patients.

Results: Sixty-three participants completed the study in the intervention and control groups. The mean age of participants was 43.3 (±8.927) and 38.7 (±8.48) years in the intervention and control groups, respectively.group showed significant reduction in alanine aminotransferase (ALT) (47.32 ± 21.77 IU/L vs. 50.03 ± 21.19, = 0.021), aspartate aminotransferase (AST) (28.29 ± 10.49 IU/L vs. 32.03 ± 13.30, = 0.004), triglyceride (TG) (200.93 ± 106.741 mg/dl vs. 183.75 ± 73.96, = 0.001), waist circumference (WC) (101.25 ± 9.27 cm vs. 101.18 ± 8.63, = 0.027), and grade of fatty liver in ultrasonography ( = 0.038), comparing to the placebo group. There was no significant difference between the two groups regarding serum levels of fasting blood sugar (FBS), high-density lipoprotein (HDL), low-density lipoprotein (LDL), cholesterol, and other outcomes.

Conclusion: supplementation with a daily dose of 2 g for 12 weeks improved serum levels of ALT, AST, and TG in patients with NAFLD. Further studies with a larger sample size are recommended.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.